| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
American Journal of Clinical Nutrition, Vol 68, 52-59, Copyright © 1998 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
S Grimsgaard, KH Bonaa, JB Hansen and ES Myhre
Institute of Community Medicine, University of Tromso, Norway. Sameline.Grimsgaard@ism.uit.no
The hemodynamic effects of highly purified eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) have not been evaluated in humans. We therefore conducted a randomized, double-blind, parallel-design intervention study to assess possible separate effects of EPA and DHA on blood pressure, heart rate, and cardiac mechanics. Healthy, nonsmoking men aged 36-56 y (n = 224) were randomly assigned to dietary supplementation with 4 g/d of ethyl ester concentrates of DHA or EPA or 4 g corn oil/d (control). Mean blood pressure at baseline was 122/77 mm Hg and was positively associated with concentrations of serum phospholipid saturated fatty acids. Blood pressure did not change during the intervention. Mean heart rate at baseline was 63.4 beats/min; it decreased 2.2 beats/min in the DHA group (P = 0.006 compared with control), increased 1.9 beats/min in the EPA group (P = 0.04 compared with control), and remained practically unchanged in the control group. In a pooled analysis, changes in heart rate were independent of baseline heart rate and were associated with changes in concentrations of serum phospholipid DHA and docosapentaenoic acid (22:5n-3). Echocardiography in a subsample of 52 men showed improved left ventricular diastolic filling in the marine oil groups compared with the corn oil group (P = 0.02). In contrast, an increase in plasma concentrations of saturated fatty acids was associated with delayed diastolic filling. We conclude that dietary DHA and EPA influence heart rate and that the fatty acid composition of plasma phospholipids may affect cardiac mechanics in humans.
This article has been cited by other articles:
|
|
 |
|
  G. G. Abdukeyum, A. J. Owen, and P. L. McLennan Dietary (n-3) Long-Chain Polyunsaturated Fatty Acids Inhibit Ischemia and Reperfusion Arrhythmias and Infarction in Rat Heart Not Enhanced by Ischemic Preconditioning J. Nutr., October 1, 2008; 138(10): 1902 - 1909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J.A. Jenkins, A. R. Josse, P. Dorian, M. L. Burr, R. LaBelle Trangmar, C. W.C. Kendall, and S. C. Cunnane Heterogeneity in Randomized Controlled Trials of Long Chain (Fish) Omega-3 Fatty Acids in Restenosis, Secondary Prevention and Ventricular Arrhythmias J. Am. Coll. Nutr., June 1, 2008; 27(3): 367 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. London, C. Albert, M. E. Anderson, W. R. Giles, D. R. Van Wagoner, E. Balk, G. E. Billman, M. Chung, W. Lands, A. Leaf, et al. Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop Circulation, September 4, 2007; 116(10): e320 - e335. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Prabodh Shah, A. M. Ichiuji, J. K. Han, M. Traina, A. El-Bialy, S. Kamal Meymandi, and R. Yvonne Wachsner Cardiovascular and Endothelial Effects of Fish Oil Supplementation in Healthy Volunteers Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 213 - 219. [Abstract] [PDF]
|
|
|
|
|
|
H. E. Theobald, A. H. Goodall, N. Sattar, D. C. S. Talbot, P. J. Chowienczyk, and T. A. B. Sanders Low-Dose Docosahexaenoic Acid Lowers Diastolic Blood Pressure in Middle-Aged Men and Women J. Nutr., April 1, 2007; 137(4): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Schwellenbach, K. L. Olson, K. J. McConnell, R. S. Stolcpart, J. D. Nash, J. A. Merenich, and for the Clinical Pharmacy Cardiac Risk Service Stu The Triglyceride-Lowering Effects of a Modest Dose of Docosahexaenoic Acid Alone Versus in Combination with Low Dose Eicosapentaenoic Acid in Patients with Coronary Artery Disease and Elevated Triglycerides J. Am. Coll. Nutr., December 1, 2006; 25(6): 480 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Shimojo, S. Jesmin, S. Zaedi, S. Maeda, M. Soma, K. Aonuma, I. Yamaguchi, and T. Miyauchi Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta1 and phosphorylated JNK Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H835 - H845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L Breslow n-3 Fatty acids and cardiovascular disease Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1477 - 1482S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. A Carpentier, L. Portois, and W. J Malaisse n-3 Fatty acids and the metabolic syndrome Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1499 - 1504S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Larnkjaer, J. H. Christensen, K. F. Michaelsen, and L. Lauritzen Maternal Fish Oil Supplementation during Lactation Does Not Affect Blood Pressure, Pulse Wave Velocity, or Heart Rate Variability in 2.5-y-old Children J. Nutr., June 1, 2006; 136(6): 1539 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.P. Jenkins, N.C. Davidson, and D.H. Bennett Successful treatment of drug refractory ventricular tachycardia by omega-3 fatty acid supplementation Europace, May 1, 2006; 8(5): 330 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mozaffarian, A. Geelen, I. A. Brouwer, J. M. Geleijnse, P. L. Zock, and M. B. Katan Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials Circulation, September 27, 2005; 112(13): 1945 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mozaffarian, C. L. Bryson, R. N. Lemaitre, G. L. Burke, and D. S. Siscovick Fish Intake and Risk of Incident Heart Failure J. Am. Coll. Cardiol., June 21, 2005; 45(12): 2015 - 2021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Geelen, I. A Brouwer, E. G Schouten, A. C Maan, M. B Katan, and P. L Zock Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans Am. J. Clinical Nutrition, February 1, 2005; 81(2): 416 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Christensen, E. B. Schmidt, E. Toft, D. Mozaffarian, E. B. Rimm, B. M. Psaty, D. S. Siscovick, R. N. Lemaitre, G. L. Burke, M. F. Lyles, et al. Letter Regarding Article by Mozaffarian et al, "Fish Intake and Risk of Incident Atrial Fibrillation" * Response Circulation, February 1, 2005; 111(4): e37 - e37. [Full Text] [PDF]
|
|
|
|
|
|
D. Mozaffarian, B. M. Psaty, E. B. Rimm, R. N. Lemaitre, G. L. Burke, M. F. Lyles, D. Lefkowitz, and D. S. Siscovick Fish Intake and Risk of Incident Atrial Fibrillation Circulation, July 27, 2004; 110(4): 368 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D Stark and B. J Holub Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy Am. J. Clinical Nutrition, May 1, 2004; 79(5): 765 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dallongeville, J. Yarnell, P. Ducimetiere, D. Arveiler, J. Ferrieres, M. Montaye, G. Luc, A. Evans, A. Bingham, B. Hass, et al. Fish Consumption Is Associated With Lower Heart Rates Circulation, August 19, 2003; 108(7): 820 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): e20 - 30. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Kris-Etherton, W. S. Harris, L. J. Appel, and for the Nutrition Committee Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease Circulation, November 19, 2002; 106(21): 2747 - 2757. [Full Text] [PDF]
|
|
|
|
|
|
R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nestel, H. Shige, S. Pomeroy, M. Cehun, M. Abbey, and D. Raederstorff The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans Am. J. Clinical Nutrition, August 1, 2002; 76(2): 326 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Christensen, M. S. Christensen, J. Dyerberg, and E. B. Schmidt Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids Am. J. Clinical Nutrition, September 1, 1999; 70(3): 331 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Mori, D. Q. Bao, V. Burke, I. B. Puddey, and L. J. Beilin Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans Hypertension, August 1, 1999; 34(2): 253 - 260. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
